Testing effectiveness (Phase 2)Ended earlyNCT04508140
What this trial is testing
Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis
Who this might be right for
Colorectal CancerGastric CancerOesophageal Cancer
Highlight Therapeutics 18